Exact Mass: 280.1803364
Exact Mass Matches: 280.1803364
Found 69 metabolites which its exact mass value is equals to given mass value 280.1803364
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
2-Aminobenzylstatine
C15H24N2O3 (280.17868339999995)
mefexamide
C15H24N2O3 (280.17868339999995)
C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant
Xylometazoline HCl
Xylometazoline hydrochloride is an α-adrenergic receptor agonist (Ki=0.05-1.7 μM). Xylometazoline hydrochloride can constrict nasal blood vessels and increase nasal airflow. Xylometazoline hydrochloride can be used in nose stuffiness and runny nose research[1][2].
Ethyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohex-3-enecarboxylate
C15H25BO4 (280.18458000000004)
Spiro[8-azabicyclo[3.2.1]octane-3,3-pyrrolidine]-8-carboxylic acid, 5-oxo-, 1,1-dimethylethyl ester
C15H24N2O3 (280.17868339999995)
Benzene, 1,1-[(2-propenyloxy)methylene]bis[2,6-dimethyl- (9CI)
2,2-bis(Hydroxymethyl)-1,3-propanediol-2-ethylhexanoate
ethyl 5-amino-2-[2-(diethylamino)ethoxy]benzoate
C15H24N2O3 (280.17868339999995)
5-Amino-2-(3-(tert-butylamino)-2-hydroxypropoxy)acetophenone
C15H24N2O3 (280.17868339999995)
tert-butyl 4-(imidazol-1-ylmethyl)-1,4-diazepane-1-carboxylate
C14H24N4O2 (280.18991639999996)
Hydroxytetracaine
C15H24N2O3 (280.17868339999995)
C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent
4-((TERT-BUTYLDIMETHYLSILYL)OXY)-4-PHENYLBUTAN-1-OL
C16H28O2Si (280.18584680000004)
N-BOC-4-[(2-FURYLMETHYL)AMINO]PIPERIDINE
C15H24N2O3 (280.17868339999995)
2,2-AZOBIS[N-(2-PROPENYL)-2-METHYLPROPIONAMIDE]
C14H24N4O2 (280.18991639999996)
((E)-4-Phenyl-but-3-enyl)-piperidin-3-ylMethyl-aMine hydrochloride
2,2-Dimethyl-3,6,9,12,15-pentaoxa-2-silahexadecane
Xylometazoline hydrochloride
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D019141 - Respiratory System Agents > D014663 - Nasal Decongestants D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents Xylometazoline hydrochloride is an α-adrenergic receptor agonist (Ki=0.05-1.7 μM). Xylometazoline hydrochloride can constrict nasal blood vessels and increase nasal airflow. Xylometazoline hydrochloride can be used in nose stuffiness and runny nose research[1][2].
(4S,7S)-4-methyl-7-(2-methylpropyl)-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one
C14H24N4O2 (280.18991639999996)
(5S,8S)-8-methyl-5-(2-methylpropyl)-3-oxa-1,6,13,14-tetrazabicyclo[9.3.0]tetradeca-11,13-dien-7-one
C14H24N4O2 (280.18991639999996)
(4S,7R)-4-methyl-7-(2-methylpropyl)-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one
C14H24N4O2 (280.18991639999996)
(1r,2s,8s,9s,10r,12r)-8,12-dihydroxy-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecan-6-one
C15H24N2O3 (280.17868339999995)
(1s,2r,5s,9s,10s,12s)-5,12-dihydroxy-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecan-6-one
C15H24N2O3 (280.17868339999995)
12,17-dihydroxy-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecan-6-one
C15H24N2O3 (280.17868339999995)
5alpha,9alpha-Dihydroxymatrine
C15H24N2O3 (280.17868339999995)
{"Ingredient_id": "HBIN011398","Ingredient_name": "5alpha,9alpha-Dihydroxymatrine","Alias": "5\u03b1,9\u03b1-dihydroxymatrine; 5alpha,9alpha-dihydroxymatrine","Ingredient_formula": "C15H24N2O3","Ingredient_Smile": "C1CC2C3CC(CN4C3C(CCC4)(CN2C(=O)C1)O)O","Ingredient_weight": "280.41","OB_score": "29.94470231","CAS_id": "NA","SymMap_id": "SMIT01028;SMIT08178","TCMID_id": "25896;5954","TCMSP_id": "MOL001998;MOL006582","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
11,12-dihydroxy-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecan-6-one
C15H24N2O3 (280.17868339999995)
4,4,7,11b-tetramethyl-1h,2h,3h,4ah-phenanthro[3,2-b]furan
8,12-dihydroxy-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecan-6-one
C15H24N2O3 (280.17868339999995)
(1s,2r,9s,10r,11s,12s)-11,12-dihydroxy-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecan-6-one
C15H24N2O3 (280.17868339999995)
9,15-dihydroxy-7,13-diazatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadecan-6-one
C15H24N2O3 (280.17868339999995)
(1r,2r,5s,9r,10s,12s)-5,12-dihydroxy-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecan-6-one
C15H24N2O3 (280.17868339999995)
9-hydroxy-6-oxo-7,13-diazatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadecan-13-ium-13-olate
C15H24N2O3 (280.17868339999995)
5,12-dihydroxy-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecan-6-one
C15H24N2O3 (280.17868339999995)
(1s,2r,9r,10r,11s,12s)-11,12-dihydroxy-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecan-6-one
C15H24N2O3 (280.17868339999995)
(4as,11bs)-4,4,7,11b-tetramethyl-1h,2h,3h,4ah-phenanthro[3,2-b]furan
(1r,9as)-1-[(2,6-dioxopiperidin-1-yl)methyl]-octahydro-1h-quinolizin-5-ium-5-olate
C15H24N2O3 (280.17868339999995)
4,5-dihydroxy-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecan-6-one
C15H24N2O3 (280.17868339999995)
(1r,2r,4s,9r,10s,12s)-4,12-dihydroxy-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecan-6-one
C15H24N2O3 (280.17868339999995)
(1s,2r,9s,10s,12s,17r)-12,17-dihydroxy-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecan-6-one
C15H24N2O3 (280.17868339999995)
1-{[(1r,7s,9ar)-7-hydroxy-octahydro-1h-quinolizin-1-yl]methyl}piperidine-2,6-dione
C15H24N2O3 (280.17868339999995)
(1r,5r,9as)-1-[(2,6-dioxopiperidin-1-yl)methyl]-octahydro-1h-quinolizin-5-ium-5-olate
C15H24N2O3 (280.17868339999995)
3-(3,5-di-tert-butyl-4-fluorophenyl)propanoic acid
(1r,2r,9r,15s,17r)-9,15-dihydroxy-7,13-diazatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadecan-6-one
C15H24N2O3 (280.17868339999995)
(1s,2r,4r,5s,9s,10s)-4,5-dihydroxy-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecan-6-one
C15H24N2O3 (280.17868339999995)
(1s,2r,8r,9r,10s,12s)-8,12-dihydroxy-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecan-6-one
C15H24N2O3 (280.17868339999995)
2,13-dihydroxy-3,10-diazatetracyclo[6.6.3.0¹,¹⁰.0³,⁸]heptadecan-4-one
C15H24N2O3 (280.17868339999995)